Associated Myocarditis: A Predictive Factor for Response?

Associated Myocarditis: A Predictive Factor for Response?

In the present case report, we aimed to describe 2 cases of myocarditis occurring as serious adverse effects of immune checkpoint inhibitors (ICIs) administered as treatment for metastatic melanoma. We describe 2 female patients: an 81-year-old treated with pembrolizumab and a 55-year-old treated wi...

Full description

Bibliographic Details
Main Authors: Walid Shalata, Nir Peled, Itzhak Gabizon, Omar Abu Saleh, Waleed Kian, Alexander Yakobson
Format: Article
Language:English
Published: Karger Publishers 2020-05-01
Series:Case Reports in Oncology
Subjects:
immune checkpoint inhibitors
myocarditis
melanoma
pembrolizumab
nivolumab
ipilimumab
Online Access:https://www.karger.com/Article/FullText/507278

Similar Items

Similar Items